Day-Care Center Attendance and Hospitalization for Lower Respiratory Tract Illness

PEDIATRICS ◽  
1988 ◽  
Vol 82 (3) ◽  
pp. 300-308
Author(s):  
Larry J. Anderson ◽  
Robert A. Parker ◽  
Raymond A. Strikas ◽  
Jeffrey A. Farrar ◽  
Eugene J. Gangarosa ◽  
...  

To identify risk factors associated with hospitalization for acute lower respiratory tract illness, 102 children <2 years of age admitted to four Atlanta metropolitan area hospitals between December 1984 and June 1985 with the diagnosis of lower respiratory tract illness were studied. The most common causative agent associated with illness was respiratory syncytial virus, followed by other respiratory viruses, Haemophilus influenzae, and Streptococcus pneumoniae. The 102 case-patients were compared with 199 age- and sex-matched controls. A parent or guardian for each patient and control was interviewed by telephone regarding demographic data, care outside the home, breast-feeding, previous medical history, allergies, and smoking and illness in household members. Five factors were associated with lower respiratory tract illness in both a univariate analysis and a multiple logistic regression model (P < .05). These factors were the number of people sleeping in the same room with the child, a lack of immunization the month before the patient was hospitalized, prematurity, a history of allergy, and regular attendance in a day-care center (more than six children in attendance). Care received outside of the home in a day-care home (less than or equal to six children in attendance) was not associated with lower respiratory tract illness. The suggestion made by our study and other studies was that for children <2 years of age, care outside of the home is an important risk factor for acquiring lower respiratory tract illness, as well as other infectious diseases, and that this risk can be reduced by using a day-care home instead of a day-care center.

2014 ◽  
Vol 2014 ◽  
pp. 1-12 ◽  
Author(s):  
Ruchi Jain ◽  
Shanmughavel Piramanayagam

HRSV (human respiratory syncytial virus) is a serious cause of lower respiratory tract illness in infants and young children. Designing inhibitors from the proteins involved in virus replication and infection process provides target for new therapeutic treatments. In the present study,in silicodocking was performed using motavizumab as a template to design motavizumab derived oligopeptides for developing novel anti-HRSV agents. Additional simulations were conducted to study the conformational propensities of the oligopeptides and confirmed the hypothesis that the designed oligopeptide is highly flexible and capable of assuming stable confirmation. Our study demonstrated the best specific interaction of GEKKLVEAPKS oligopeptide for glycoprotein strain A among various screened oligopeptides. Encouraged by the results, we expect that the proposed scheme will provide rational choices for antibody reengineering which is useful for systematically identifying the possible ways to improve efficacy of existing antibody drugs.


2010 ◽  
Vol 32 (14) ◽  
pp. 2422-2432 ◽  
Author(s):  
José R. Romero ◽  
Dan L. Stewart ◽  
Erin K. Buysman ◽  
Ancilla W. Fernandes ◽  
Hasan S. Jafri ◽  
...  

F1000Research ◽  
2019 ◽  
Vol 8 ◽  
pp. 610 ◽  
Author(s):  
Sofia Jares Baglivo ◽  
Fernando P Polack

Severe respiratory syncytial virus (RSV) lower respiratory tract illness (LRTI) in infants has proven challenging to prevent. In the last 50 years, conceptually different approaches failed to evolve into viable preventive alternatives for routine use. Inactivated RSV vaccine (that is, formalin-inactivated RSV) elicited severe LRTI in RSV-infected toddlers pre-immunized as infants; early purified F protein approaches in pregnant women failed to elicit sufficient immunity more than a decade ago; a second-generation monoclonal antibody (mAb) of high potency against the virus (that is, motavizumab) caused severe adverse reactions in the skin, and owing to lack of efficacy against RSV subgroup B, an extended half-life mAb targeting site V in the RSV fusion protein (that is, REG2222) did not meet its primary endpoint. In the meantime, two protein F vaccines failed to prevent medically attended LRTI in the elderly. However, palivizumab and the recent results of the Novavax maternal immunization trial with ResVax demonstrate that severe RSV LRTI can be prevented by mAb and by maternal immunization (at least to a certain extent). In fact, disease prevention may also decrease the rates of recurrent wheezing and all-cause pneumonia for at least 180 days. In this review, we discuss the history of RSV vaccine development, previous and current vaccine strategies undergoing evaluation, and recent information about disease burden and its implications for the effects of successful preventive strategies.


Viruses ◽  
2012 ◽  
Vol 4 (11) ◽  
pp. 2432-2447 ◽  
Author(s):  
Luiz Gardinassi ◽  
Paulo Simas ◽  
Deriane Gomes ◽  
Caroline Bonfim ◽  
Felipe Nogueira ◽  
...  

PEDIATRICS ◽  
1972 ◽  
Vol 49 (3) ◽  
pp. 428-437 ◽  
Author(s):  
Frank A. Loda ◽  
W Paul Glezen ◽  
Wallace A. Clyde

The frequency of occurrence and etiology of respiratory disease during a 40-month period in a day care center is reported. The day care center had a maximum enrollment of 39 children ranging in age from 1 month to 5 years. Sick children were not excluded from the center. During the period of the study there was not an excessive amount of respiratory illness in the children in day care when compared with the reported illness occurrence in children receiving home care. In the total group there were 8.4 respiratory illnesses per child-year with the highest rate in infants under 1 year of age. The agents responsible for the respiratory disease in the day care center were similar to those reported as significant in the community, and the patterns of virus isolation were similar to those in the community in age incidence, seasonal occurrence, and illness association. Respiratory syncytial virus and parainfluenza virus type 3 were the agents most often implicated in lower respiratory disease. Adenovirus types 2 and 5 frequently caused febrile upper respiratory illness in infants. The study suggests group day care is safe medically for infants and that exclusion of sick children is unnecessary in a day care program with adequate space and staffing.


Sign in / Sign up

Export Citation Format

Share Document